ICD-10-CM Billable Code

F20.0

Paranoid schizophrenia

Clinical Classification Guidelines

Inclusion Terms

  • Paraphrenic schizophrenia

Excludes Type 1

  • involutional paranoid state (F22)
  • paranoia (F22)

Medical Intelligence & Overview

Paranoid schizophrenia, identified by the ICD-10 code F20.0, is a chronic mental health disorder characterized by prominent delusions of persecution or grandeur, often accompanied by auditory hallucinations. It is a subtype of schizophrenia, a serious mental illness that affects how a person thinks, feels, and behaves. Historically referred to as paraphrenic schizophrenia, this condition primarily involves a pattern of thematic delusions and often reserved emotional response. Recognizing and understanding the symptoms and causes can be essential for proper management and treatment.

Causes & Symptoms

Clinical Causes: Genetics: Family history of schizophrenia or other psychotic disorders can increase the risk. Neurochemical factors: Imbalances in brain chemicals like dopamine and serotonin are believed to play a role. Environmental factors: Stressful life events, trauma, or substance abuse during critical developmental periods may contribute. Brain structure abnormalities: Variations in brain anatomy, such as enlarged ventricles or reduced gray matter, have been observed. Prenatal exposures: Infections or malnutrition during pregnancy may influence the development of schizophrenia later in life.

Key Symptoms: Persistent delusions, often involving themes of persecution, conspiracy, or grandiosity. Auditory hallucinations, such as hearing voices that others do not hear. Disorganized thinking: Difficulties in organizing thoughts, leading to incoherent speech. Social withdrawal and reduced emotional expression. Lack of motivation and decreased interest in daily activities. Anxiety or agitation, sometimes accompanied by suspiciousness. Difficulty distinguishing between reality and hallucinations or delusions.

Diagnostic & Treatment

Diagnosis Path: Diagnosing paranoid schizophrenia involves a comprehensive clinical assessment by a mental health professional. This process typically includes a detailed interview to evaluate symptoms, medical history, and mental state. Standardized diagnostic criteria, such as those outlined in the DSM-5, are used to confirm the diagnosis. Sometimes, laboratory tests or neuroimaging like MRI scans may be employed to rule out other possible causes of psychosis. It is important to distinguish paranoid schizophrenia from other psychotic disorders or mood disorders with psychotic features.

Treatment Protocols: Management of paranoid schizophrenia often involves a combination of medication, therapy, and social support. Antipsychotic drugs are the mainstay, helping to reduce hallucinations and delusions. Psychosocial interventions, including cognitive-behavioral therapy (CBT), can assist individuals in coping with symptoms, improving social functioning, and reducing relapse risk. Family education and support groups are beneficial in creating a supportive environment. In some cases, hospitalization may be necessary to stabilize acute episodes. Long-term treatment aims to enable individuals to lead more functional and productive lives while minimizing symptom relapse.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F20.0 a billable ICD-10 code?
Yes, F20.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F20.0?
Clinical documentation must specify the nature of Paranoid schizophrenia and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Related Diagnosis Codes

Clinical Meta Tags

paranoid schizophrenia